NEW YORK, August 2, 2018 /PRNewswire/ --
According to research published by Technavio, the legal cannabis market is projected to grow at a CAGR of about 24% by 2021.
Increasing popularity of CBD oil is one of the primary growth factors for the market. The research indicates that the expanding
influence of online retailing in states where cannabis products were legalized helps increase sales. Customers prefer to pay
using debit cards or credit cards, thereby avoiding time-consuming journeys and billing queues. The extensive use of online
retailing by consumers is drawing the attention of manufacturers who are planning to focus on the internet-savvy customer segment
and explore the new online retail format. CLS Holdings USA Inc. (OTC: CLSH), Molson Coors
Brewing Company (NYSE: TAP), GW Pharmaceuticals plc (NASDAQ: GWPH), Innovative Industrial Properties, Inc. (NYSE: IIPR), Emerald
Health Therapeutics Inc. (OTC: EMHTF)
A major sector of the cannabis industry is cannabis edibles, also known as cannabis-infused foods. Technavio's market research
expects that the edible products market will witness considerable growth during the period 2018-2022 and register a CAGR of over
25% by the end of the period. Edible products are intended to be used for both medical and recreational purposes, depending on
its cannabinoid compounds. The recent trend of legalization for recreational purposes help increase the popularity of such
products. Cannabis is now widely accepted in countries such as the US, Canada, Spain,
Chile, Israel, Germany, and
Australia.
CLS Holdings USA Inc. (OTCQB: CLSH) announced last week the, "appointment of
Frank Tarantino as Chief Financial Officer. Mr. Tarantino brings big four public accounting and
private and public company management and financial expertise, which will be extremely beneficial in leading the Company through
its next phase in organic growth and acquisitions.
Mr. Tarantino stated, "I am pleased to join CLS post acquisition of Oasis Cannabis and look forward to working with the
executive team in its strategic transition into vertically integrated operations, and expanding its operations in Nevada and other key markets."
Mr. Tarantino has more than 18 years of executive management experience in public and private companies and six years of
experience in public accounting. Prior to joining CLS, Mr. Tarantino was the COO/CFO of Wild Things, an outdoor clothing
manufacturer and retailer serving the US Military and foreign governments. Prior to Wild Things, Mr. Tarantino worked as the Vice
President of Finance at Cornerstone Brands, an acquisition and holding company concentrating on high end, online and direct mail
retailers. Mr. Tarantino was involved with several acquisitions and managed the company's bank syndicated credit line, which
peaked at $135 million. Mr. Tarantino also worked on raising capital for both Wild Things and
Cornerstone Brands. In the early stages of his career, Mr. Tarantino worked as an auditor for Coopers and Lybrand, now
Pricewaterhouse Coopers, in the Boston office where he concentrated on auditing financial
institutions, banks, broker dealers and institutional investors.
Mr. Tarantino earned a BS in Accounting and Finance from Babson College, Wellesley, MA and earned his Certified Public Accountant Certificate from the State of Massachusetts."
Mr. Lamadrid has elected to resign due to personal considerations. CLS Chief Executive Officer Jeff
Binder stated, "We thank Mr. Lamadrid for working with us as we expanded into vertically integrated operations, and seeing
us through the entire process of acquiring Oasis."
Molson Coors Brewing Company (NYSE: TAP) business unit Molson Coors Canada and leading
Canadian cannabis producer, The Hydropothecary Corporation, announced on August 1st, 2018 that they
have entered into a definitive agreement to form a joint venture to pursue opportunities to develop non-alcoholic,
cannabis-infused beverages for the Canadian market following legalization. "Canada is breaking new ground in the cannabis sector
and, as one of the country's leading beverage companies, Molson Coors Canada has a unique
opportunity to participate in this exciting and rapidly expanding consumer segment. This new venture is consistent with our
growth strategy and our commitment to being First Choice for Consumers and Customers by ensuring that Canadians have access to
high-quality products that meet their evolving drinking preferences," said Frederic Landtmeters, President and Chief Executive
Officer of Molson Coors Canada. "While we remain a beer business at our core, we are excited to
create a separate new venture with a trusted partner that will be a market leader in offering Canadian consumers new experiences
with quality, reliable and consistent non-alcoholic, cannabis-infused beverages. We look forward to partnering with HEXO, a
recognized leader in the medical cannabis space in Canada that will bring robust production
capacity, a track record of innovation, and, most importantly, shared values when it comes to doing business the right way and
earning the trust of consumers."
GW Pharmaceuticals plc (NASDAQ: GWPH) is a biopharmaceutical company focused on discovering, developing and
commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. On
June 25, 2018, the Company announced that the U.S. Food and Drug Administration(FDA) has approved
EPIDIOLEX® (cannabidiol) oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet
syndrome in patients two years of age or older. EPIDIOLEX is the first prescription pharmaceutical formulation of
highly-purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the high associated with marijuana, and the first in a
new category of anti-epileptic drugs (AEDs). Product availability is pending rescheduling which is expected to occur within 90
days. The EPIDIOLEX clinical development program included three randomized, controlled Phase 3 clinical trials and an open-label
extension study.
Innovative Industrial Properties, Inc. (NYSE: IIPR) is a self-advised Maryland
corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced,
state-licensed operators for their regulated medical-use cannabis facilities. In July, the Company announced that it closed on
the acquisition of a property located at 96 Palmer Road in Monson, Massachusetts, which
comprises approximately 55,000 square feet of industrial space situated on approximately 5.4 acres. The purchase price for the
property was $12.75 million. Concurrent with the closing of the purchase, the Company entered into
a long-term, triple-net lease agreement with Holistic Industries, Inc. ("Holistic"), which intends to continue to operate the
property as a medical-use cannabis cultivation and processing facility in accordance with Massachusetts medical-use cannabis regulations. The initial term of the lease is 20 years, with three
options to extend the term for three additional five-year periods.
Emerald Health Therapeutics Inc. (OTCQX: EMHTF) announced this week that their that their 50/50 joint venture for
large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received its cannabis sales license from Health
Canada. Pure Sunfarms is now permitted to immediately begin selling product from its expanding inventory of high-quality dried
cannabis, including to Emerald Health Therapeutics, under their previously announced supply agreement, as well as to address
significant demand from other licensed producers. This sales license also positions Pure Sunfarms to secure supply agreements
with provincial government distributors for the imminent legal adult-use marketplace. "Pure Sunfarms is moving at remarkable
speed to become a significant cannabis supplier and, with our high operational quality standards, we achieved a very rapid
turnaround on this license. We greatly appreciate Health Canada's timely responses to all of our submissions," said Chris Wagner, CEO, Emerald Health Therapeutics.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For CLS Holdings USA Inc. financial news
dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the
company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or
site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and
the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in
securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the
information on the editorial or Site or continue to post information about any companies the information contained herein is not
intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site,
company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors
accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation
of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and
website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time.
None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication
is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree
to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change
without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: http://www.FinancialBuzz.com
SOURCE FinancialBuzz.com